<SEC-DOCUMENT>0001193125-17-324941.txt : 20171030
<SEC-HEADER>0001193125-17-324941.hdr.sgml : 20171030
<ACCEPTANCE-DATETIME>20171030161923
ACCESSION NUMBER:		0001193125-17-324941
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20171030
DATE AS OF CHANGE:		20171030
EFFECTIVENESS DATE:		20171030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UroGen Pharma Ltd.
		CENTRAL INDEX KEY:			0001668243
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-221212
		FILM NUMBER:		171162558

	BUSINESS ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
		BUSINESS PHONE:		972 9 770 7601

	MAIL ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d483289ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML><HEAD>
<TITLE>Form S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on October&nbsp;30, 2017 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>UroGen Pharma Ltd. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>State of Israel</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Note Applicable</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9 Ha&#146;Ta&#146;asiya Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ra&#146;anana 4365007, Israel</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Not Applicable</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2010 Israeli Share Option Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full titles of the plans) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Urogen Pharma, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>689
Fifth Avenue, 14th Floor </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10022 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>+1 (646) <FONT STYLE="white-space:nowrap">768-9780</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Divakar Gupta</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Daniel I. Goldberg</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Joshua
A. Kaufman</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Grace Building</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1114
Avenue of the Americas</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>New York, NY 10036</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>+1 (212) <FONT STYLE="white-space:nowrap">479-6000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Gary Titus</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Financial Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UroGen Pharma Ltd.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9
Ha&#146;Ta&#146;asiya Street</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ra&#146;anana 4365007, Israel</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>+972 (9) <FONT STYLE="white-space:nowrap">770-7601</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
<FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting
company,&#148; and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9746; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION
OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of securities <BR>to be registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registered&nbsp;(1)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering
price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>per share</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering price</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registration fee</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2010 Israeli Share Option Plan</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ordinary Shares, par value NIS 0.01 per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">2,486,858&nbsp;shares&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$4.26&nbsp;(3)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$10,600,000&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$1,320</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this Registration Statement shall also cover any additional shares of the Registrant&#146;s Ordinary Shares
(&#147;Ordinary Shares&#148;) that become issuable under the 2010 Israeli Share Option Plan (the &#147;Plan&#148;) by reason of any stock dividend, stock split, recapitalization or other similar transaction. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents 2,486,858 Ordinary Shares reserved for issuance under the Plan. No further equity grants will be made pursuant to the Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">This estimate is made pursuant to Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee. The proposed maximum offering price per share and proposed maximum aggregate offering price
are calculated using a weighted average exercise price for such shares. </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;1. PLAN INFORMATION. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not required to be filed
with this Registration Statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;2. REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not required to be filed with this Registration Statement. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;3. INCORPORATION OF DOCUMENTS BY REFERENCE. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed by the Registrant with the
Commission: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The Registrant&#146;s prospectus filed on May&nbsp;5, 2017 pursuant to Rule 424(b) under the Securities Act, relating to the
registration statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> originally filed on April&nbsp;24, 2017, as amended (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-217201),</FONT> which contains audited financial statements for the
Registrant&#146;s latest fiscal year for which such statements have been filed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The description of the Registrant&#146;s Ordinary Shares
contained in the Registrant&#146;s registration statement on Form <FONT STYLE="white-space:nowrap">8-A</FONT> filed on May&nbsp;1, 2017 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-38079)</FONT> under the Securities Exchange Act of 1934, as
amended (the &#147;Exchange Act&#148;), including any amendment or report filed for the purpose of updating such description. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) </B>The
Registrant&#146;s report on Form <FONT STYLE="white-space:nowrap">6-K</FONT> filed on May&nbsp;18, 2017 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-38079)</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d)</B> The Registrant&#146;s report on Form <FONT STYLE="white-space:nowrap">6-K</FONT> filed on July&nbsp;19, 2017 (File
<FONT STYLE="white-space:nowrap">No.&nbsp;001-38079)</FONT> under the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(e)</B> The Registrant&#146;s report on Form <FONT
STYLE="white-space:nowrap">6-K</FONT> filed on August&nbsp;14, 2017 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-38079)</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(f)</B> The Registrant&#146;s report on Form <FONT STYLE="white-space:nowrap">6-K</FONT> filed on August&nbsp;29, 2017 (File
<FONT STYLE="white-space:nowrap">No.&nbsp;001-38079)</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All documents, reports and definitive proxy or information statements
filed pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or
which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents, reports
and definitive proxy or information statements, or portions thereof, which are furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement
contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement herein or in any other subsequently filed
document which also is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any such statement so modified or superseded shall not constitute a part of this Registration Statement, except as so modified or
superseded. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;4. DESCRIPTION OF SECURITIES. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;5. INTERESTS OF NAMED EXPERTS AND
COUNSEL. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;6.
INDEMNIFICATION OF DIRECTORS AND OFFICERS. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Israeli Companies Law, 5759-1999, or the Israeli Companies Law, a company may not exculpate an
office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of
care but only if a provision authorizing such exculpation is included in its articles of association. The Registrant&#146;s Articles of Association include such a provision. A company may not exculpate in advance a director from liability arising
out of a breach of the duty of care with respect to a distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Israeli Companies Law, a company may indemnify an office holder in respect
of the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of an event or following an event, provided its articles of association include a provision
authorizing such indemnification: </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#146;s award approved by a court. However, if an undertaking to indemnify an office
holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#146;s activities when the undertaking to
indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and amount or criteria; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reasonable litigation expenses, including attorneys&#146; fees, incurred by the office holder (1)&nbsp;as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct
such investigation or proceeding, provided that (i)&nbsp;no indictment was filed against such office holder as a result of such investigation or proceeding, and (ii)&nbsp;no financial liability was imposed upon him or her as a substitute for the
criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and (2)&nbsp;in connection with a monetary
sanction; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reasonable litigation expenses, including attorneys&#146; fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf, or by a third party, or in
connection with criminal proceedings in which the office holder was acquitted, or as a result of a conviction for an offense that does not require proof of criminal intent. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Israeli Companies Law, a company may insure an office holder against the following liabilities incurred for acts performed by him or her as an
office holder, if and to the extent provided in the company&#146;s articles of association: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a breach of the duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a financial liability imposed on the office holder in favor of a third party. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Israeli Companies
Law, a company may not indemnify, exculpate or insure an office holder against any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe
that the act would not harm the company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an act or omission committed with intent to derive illegal personal benefit; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a fine, civil fine, monetary sanction or forfeit levied against the office holder. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Israeli
Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with respect to certain office holders or under certain circumstances,
also by the shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant has obtained directors and officers liability insurance for the benefit of the Registrant&#146;s office holders.
The Registrant intends to maintain such coverage and pay all premiums thereunder to the fullest extent permitted by the Israeli Companies Law. In addition, the Registrant has entered into agreements with each of the Registrant&#146;s directors and
executive officers exculpating them from liability to us for damages caused to us as a result of a breach of duty of care and undertaking to indemnify them, in each case, to the fullest extent permitted by the Registrant&#146;s Articles of
Association and Israeli law. In the opinion of the U.S. Securities and Exchange Commission, however, indemnification of directors and office holders for liabilities arising under the Securities Act is against public policy and therefore
unenforceable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;7. EXEMPTION FROM REGISTRATION CLAIMED. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;8. EXHIBITS. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1668243/000119312517175069/d401998dex31.htm">Articles of Association of the Registrant.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d483289dex51.htm">Opinion of Hamburger Evron&nbsp;&amp; Co., Israeli counsel to the Registrant, as to the validity of the Registrant&#146;s Ordinary Shares. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d483289dex231.htm">Consent of Independent Registered Public Accounting Firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d483289dex51.htm">Consent of Hamburger Evron&nbsp;&amp; Co. Reference is made to Exhibit 5.1. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Powers of Attorney. Reference is made to the signature page hereto. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1668243/000119312517116003/d142578dex102.htm">2010 Israeli Share Option Plan.</A></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Previously filed as Exhibit 3.1 to the Registrant&#146;s Report on Form 6-K furnished to the Commission on May 18, 2017, and incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Previously filed as Exhibit 10.2 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-217201),</FONT> originally filed
with the Commission on April&nbsp;24, 2017, as amended, and incorporated herein by reference. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ITEM&nbsp;9. UNDERTAKINGS. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned Registrant UroGen Pharma Ltd., hereby undertakes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">to file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">to reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in this Registration Statement; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">to include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that paragraphs (i)&nbsp;and (ii) do not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are incorporated by reference in the
registration statement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">that, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; and </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#146;s annual report
pursuant to Sections 13(a) or 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Ra&#146;anana, Israel, on
October&nbsp;30, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>UROGEN PHARMA LTD.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Ron Bentsur</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Ron Bentsur</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWERS OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ron Bentsur and Gary Titus, and each of them, as his or
her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all
capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission,
granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be
done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:15.95pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:16.00pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ron Bentsur</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Ron Bentsur</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Executive Officer and</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Member of the Board of Directors</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Principal Executive Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gary Titus</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gary Titus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Principal Financial and Accounting Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arie Belldegrun, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Arie Belldegrun, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chairman of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fred Cohen</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Fred Cohen, M.D., D. Phil.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Member of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kathryn E. Falberg</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kathryn E. Falberg</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Member of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stuart Holden, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stuart Holden, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Member of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chaim Hurvitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Member of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ran Nussbaum</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Ran Nussbaum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Member of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Pini Orbach, Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Pini Orbach, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Member of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;30, 2017</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>UroGen Pharma, Inc.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ron Bentsur</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Authorized U.S. Representative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;30,&nbsp;2017</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ron Bentsur</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d483289dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g483289g1030053821224.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Shai Pines</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Yael Urieli</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tal <FONT STYLE="white-space:nowrap">Dan-Gour</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gilad&nbsp;Goni</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Arie&nbsp;Hamburger</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">1900-1976</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Haim Waintrob</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Yif&#146;at Fux</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tzahi Nahum</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adva&nbsp;Benor</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Amnon Evron</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">1931-2006</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Gabriel&nbsp;Moyal-Maor</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eleanor Stark</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Karin Bresler</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Einat&nbsp;Amidi</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Amnon Sorek</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Achai Gomeh</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Oshri Yamin</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Shaked&nbsp;Nissan-Cohen</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Menachem&nbsp;Abramovich&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ram Museri</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Zohar Ilan</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Itai Shance</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dor Shacham</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sarit&nbsp;Rozenberger&nbsp;Zada&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Inbar&nbsp;Ben&nbsp;Shushan&nbsp;Kogeus&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Bat El Levy</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Yaron Sobol</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Itay Chelouche</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Nisim Menashe</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Gal Rosenzweig</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Ronen Yardeni</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ori Sharon</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tom Wolfstein</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Zeev&nbsp;Milner,&nbsp;of&nbsp;counsel</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Assaf Englard</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Anat Libin</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Yossi Hazan</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Steven Berelowitz</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Doron Dorfman</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Asaf Naymark</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Ori Primo</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Liat Elpaz</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Rotem Paist</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yaron Sobol, Adv. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hamburger Evron&nbsp;&amp; Co. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Museum Tower </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4 Berkowitz St. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel Aviv 6423806 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Israel </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">October&nbsp;30, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UroGen Pharma Ltd. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9 Ha&#146;Ta&#146;ssiya Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ra&#146;anana 4365007 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Israel </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Re: Registration Statement
on Form <FONT STYLE="white-space:nowrap">S-8</FONT> </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as Israeli counsel for UroGen Pharma Ltd., an Israeli company (the &#147;<B>Company</B>&#148;), in connection with the Registration Statement on
Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;<B>Registration Statement</B>&#148;) filed by the Company on the date hereof with the U.S. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g483289g1030053821504.jpg" ALT="LOGO">
 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g483289g1030053821224.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;) under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;). The Registration Statement relates to the
registration of 2,486,858 of the Company&#146;s ordinary shares, nominal value NIS 0.01&nbsp;per share (the &#147;<B>Shares</B>&#148;), issuable under the 2010 Israeli Share Option Plan (the &#147;<B>Plan</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection herewith, we have examined the originals, or photocopies or copies, certified or otherwise identified to our satisfaction, of: (i)&nbsp;the
Registration Statement to which this opinion is attached as an exhibit; (ii)&nbsp;a copy of the articles of association of the Company, as currently in effect; (iii)&nbsp;resolutions of the board of directors (the &#147;<B>Board</B>&#148;) and the
shareholders of the Company, which relate to the Registration Statement and the Plan; and (iv)&nbsp;such other corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public officials and of
officers and representatives of the Company as we have deemed relevant and necessary as a basis for the opinions hereafter set forth. We have also made inquiries of such officers and representatives as we have deemed relevant and necessary as a
basis for the opinions hereafter set forth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural
persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, confirmed as photostatic copies and the authenticity of the originals of such latter
documents. As to all questions of fact material to these opinions that have not been independently established, we have relied upon certificates or comparable documents of officers and representatives of the Company. In addition, we have assumed
that the Shares and any equity awards that provide for the acquisition thereof will be granted in accordance with the Plan and the Company&#146;s articles of association. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing, we are of the opinion that the issuance of the Shares pursuant to the Plan has been duly and validly authorized and
that, upon the grant of any such Shares or awards, and the vesting, exercise and/or settlement, as the case may be, of any equity awards to acquire Shares, in each case pursuant to the Plan and the articles of association, such Shares will be
validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of our firm are admitted to the Bar in the State of
Israel, and we do not express any opinion as to the laws of any other jurisdiction. This opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that we are within the
category of persons whose consent is required under Section&nbsp;7 of the Securities Act, the rules and regulations of the SEC promulgated thereunder or Item&nbsp;509 of the SEC&#146;s Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the
Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered as of the date hereof and we disclaim any obligation to advise you of facts, circumstances, events or
developments that may be brought to our attention after the effective date of the Registration Statement that may alter, affect or modify the opinions expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hamburger Evron&nbsp;&amp; Co. </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Yaron Sobol</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Yaron Sobol, Adv.</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g483289g73m29.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d483289dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> of our report dated
March&nbsp;8, 2017, except for the effects of the share split discussed in note 1d to the consolidated financial statements, as to which the date is April&nbsp;24, 2017, relating to the financial statements of UroGen Pharma Ltd., which appears in
Amendment No.&nbsp;1 to the Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-217201).</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="57%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">/s/ Kesselman&nbsp;&amp; Kesselman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Tel-Aviv,</FONT> Israel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kesselman&nbsp;&amp; Kesselman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">October&nbsp;30, 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certified Public Accountants (Isr.)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A member firm of PricewaterhouseCoopers International Limited</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Kesselman</I>&nbsp;&amp; <I>Kesselman, Trade Tower, 25 Hamered Street, <FONT STYLE="white-space:nowrap">Tel-Aviv</FONT>
6812508, Israel, </I> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>P.O Box 50005 <FONT STYLE="white-space:nowrap">Tel-Aviv</FONT> 6150001 Telephone: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">+972-3-7954555,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fax:+972-3-7954556,</FONT></FONT> www.pwc.com/il </I></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g483289g1030053821224.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483289g1030053821224.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !J +(# 2(  A$! Q$!_\0
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MR?'#1%FVIIM^\?\ ?^4?IG-<#X4\&:M\0M2GU&^NY$MM_P"_NWY9V_NKG_\
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<%!'!'?/3]:VZ6I6%C=.^UOP*]JPHHHKI,C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g483289g1030053821504.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483289g1030053821504.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 H@# 2(  A$! Q$!_\0
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MS,X$:C^(GI6$NAW[QQ22%?.F?9=?-_RSR,8_ ?K6YJ=D;VQ:&-@DBD/&3T#
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MGCN85EA</&W1A7/?V9<-;32R6DSR/*C -<#S!M'# XQFM:PANUTH17+@7!#
M'CY<],X[UM1K592M*/3L_P!?R(G"*6C*%GK%U<:K]G81>7N=7C4'=$%Z%CTY
MK2U.Y>TTR>XA"ET3*[NF:YW^Q[\Q1I':^5(B[;A_.XN1G./Q]:Z#4;>2YT>6
M"*,+(\>%0GI[5C0G6=.:E>]M/N_K]-"YJ"DK%1=9DDTI9PBI<K*D4L;#[I)
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M1WT5F6)GE4NJJI.%'<^@^M+DE_,_P_R'S+L1_:KK_GQ?_OX*/M5U_P ^+_\
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M/\@YEV*?VJZ_Y\7_ ._@H^U77_/B_P#W\%7**.27\S_#_(+KL4_M5U_SXO\
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M:' -TSL5$@2.)G8H5W;L 9V@'D]J/93[O\/\@YX]BY+?SPQ[WL7"@@??%/\
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M3W"-\QW\KDCDC./I5_P?HVHZ7)>27D,%M'($5(((U494<L0I(R?S]:WO-O\
M_GUB_P"_O_UJ/-O_ /GUB_[^_P#UJIXBZM9_<R?9ZW..M?"&I1P6T#B);=H6
M>YB#_>G7<(_P(89_W13VT'6H46TBLXI(YI[6>28S "/RP@9<=2?DX(]:Z[S;
M_P#Y]8O^_O\ ]:CS;_\ Y]8O^_O_ -:CZQY/[F'LCAYO"VK/!-%;6%M;0I,L
MIB9EE-V0S$[N@(YR-_/KFK-OH.NZ?91R);0W,[P7$)@5UB6 2,"N.HP,=!^%
M=?YM_P#\^L7_ ']_^M1YM_\ \^L7_?W_ .M1]8\OP8>R.._X0N6:U8W%E;O=
M$V@#EP2$15#@'L.#]:Z70-,?2DOX/*CBMWNWDMXXS\JH0.@[<YXJYYM__P ^
ML7_?W_ZU'FW_ /SZQ?\ ?W_ZU)U[JVOW,%3L<I_PCU]#I^E+<:7;ZFMM!)%)
M9R2J%5V;(<9X/''J,\56?P?K*)$D<T9V0+<9W_\ +U'GRQSR5P0,_P"R*[3S
M;_\ Y]8O^_O_ -:CS;__ )]8O^_O_P!:G]8\G]S#V1PE]X.UMC 8!;2/+;A7
M:15<VTQ8LSJ21CD]5YX%=)HFF/H]Q.SV >YO;R5Y+E,$B/JI8]><#CU-:_FW
M_P#SZQ?]_?\ ZU'FW_\ SZQ?]_?_ *U#Q%U:S^Y@J=CGM5\-:K/K,=_:ZC&5
M:\BE9)+<$QH@(P&W<CD\8[U'XGT*YU'6VN%TQKV%['[.I2\\G8^XG+#(W#D>
MOTKI?-O_ /GUB_[^_P#UJ/-O_P#GUB_[^_\ UJ%7\G]S#V9Q5UX6\02:K#*9
M;:9G6WS=&)=UN4 #;22"N2"?E'.>:=-X)NY-&LX+9+>UO%N9I[B3@B3+,55\
M<LI! (KLS-?@9^RQ?]_?_K5'#=WL\*RI:1[6&1F7_P"M1]9UM^C#V1RMSH&I
MW<\SR:3;BXNC$T5WYPW6.T %5[X&#C;USS4,_A#6#/)Y4B")93;0_O,8M)"6
M<_4$C _V!7:>;?\ _/K%_P!_?_K4>;?_ //K%_W]_P#K4?6/)_<P]D<O/X=N
M8[^&[72;6],4]QM21EX1E 3DCH,8QVS6CX=TZ:PT>ZB_L>"SN9"79"R;)7(]
M$Z+VQCI6OYM__P ^L7_?W_ZU'FW_ /SZQ?\ ?W_ZU)UTU:S^Y@J9R$^@ZE>[
M99=%@6"":!TLI)UE#%6^<J3PHQQCOCM7565W?/,(+K3O(X9@Z.&15!PHSZD<
MX[5+YM__ ,^L7_?W_P"M1YM__P ^L7_?W_ZU#KI]']S&J=NIA:UH6H7YUO[,
MZ1&[@@6)B<[MA)92/0CC\:IZ#X?U6UO[2YN88(8DN9)/(B54$2F(ID*I(R3Z
M5U/FW_\ SZQ?]_?_ *U'FW__ #ZQ?]_?_K4_;Z6L_N8O9ZW.:U3PSJVL7FIW
M)OH;42A8K=&@$A"H=RL&R-N6YH71-8FGD\Y4CMS$]RD8ER5NG3:5_P!T'<V?
M5O:NE\V__P"?6+_O[_\ 6H\V_P#^?6+_ +^__6H^L>3^YA[/^KF%I^AZA;ZS
M$)"HTR,"Y #Y/GE=I7']WC</?-5;O0M4?Q/->PPGS9)HFCOQ=%1%"N-T9C_B
M_B[?Q9KI_-O_ /GUB_[^_P#UJ/-O_P#GUB_[^_\ UJ7M_)_<P]F<Q#X>UK3-
M7>]2XAU%/LTP:-X5C::1F4A6.3Z=?08JU!#JQLKR6;1BUW.5$P>[53*GHA7[
MN.V2/K6[YM__ ,^L7_?W_P"M1YU__P ^L7_?W_ZU'MT^C^YA[,XQ_#&I)86<
M<M@+J*,3A+9;ORVAWME=TG5\#@^OO5C^P=:2&;3V@MY8[X6[3W2.$$)155P%
MZG[O&/6NK\V__P"?6+_O[_\ 6H\V_P#^?6+_ +^__6I_6/)_<P]D<GI^C:MI
M6J27OV24NLDTUS-'<[_MH.=BB,G"D<#/&,5M:WIUUJGV)XX%(6.7S8WDVXWQ
MXQD>YQD5I>;?_P#/K%_W]_\ K4>;?_\ /K%_W]_^M2==-WL_N8>SZ'):?X7N
M7N+%KG2K2"UMI972%BK;28P%9@/E)R.V/7K6;%X0UUX[\;1;RSP 2,9$*S.)
M-Q&U0#M(X^8D]C7?^;?_ //K%_W]_P#K4UY[Y$9S:1849/[W_P"M3^LVZ/[F
M'LCG/#V@ZG9W<-Q=1P11B:1Q!$JHL0*!>%4D<D9XKL:H17-]+$LBVD6UAD9E
M_P#K4_SK_P#Y]8O^_O\ ]:I==2UL_N8U"VA<HID9<QJ9%"N1R <@4V=IE4&&
M-7;/(9MM4WI<+:V.>\5Z1<ZE+82QVC7L-NSLUNMQY#!BN%<-D=.?SK-N/"NN
MS)I<[ZI%+<6YA#J\(;8%.6(8G)]_7%=9YM__ ,^L7_?W_P"M1YM__P ^L7_?
MW_ZU"KV5K/[F)T[F*O\ ;,NK7%W/HYW11LEIFZ3:!W/J&;'7M6%_PC6M^2\W
MDW.\WHG ^V)]JQY>W_6XV]>V.E=OYM__ ,^L7_?W_P"M1YM__P ^L7_?W_ZU
M"KI=/P8>SOU.(@\-:Y::;<6:VD<O]H0+%)(TXS 0YY;^^=IR2.]:.G:#J-KX
MF-U]G:,-<R2SWGVHE9XR"$3R\\$?*,X_AKIO-O\ _GUB_P"_O_UJ/-O_ /GU
MB_[^_P#UJ'B/)_<P]D9?B(:I>P-8VFE^;&9(V,YG11A6#' /.>*74[>\M].N
M[+3-,-Q]K25V=IU4+(^<YSSC)[5I^;?_ //K%_W]_P#K4>;?_P#/K%_W]_\
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M2S^YB]F8XTB^CF\U41BNHS7(!?JK1.J_JPJA'H6HVUII.GVMJL265O*6G64
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MMGAQK88S+"RC/J<X_6L/^7B]'^AK]EC(_$5G-=36\:RM)%>"S8;1R^W=D<]
M ?RK7KCM$\.ZC:ZEIMS>"+"VQ:ZVMG-SG&X>ORDBNQK622V(5^H4445(PIJR
M(PRKJ03C@U0U^RN=1T&]L[.8PW$T15'#8P?KV]*Y;3_#%[:Z5=206;V]XDL<
M]K#-/&PWIU_U:A5R"1GJ<\U22:W$V[G<>8@."ZY)P!F@2(=V'4[>O/2N3M?"
MLBW<$\\<33)9,//;#%+EW+,X'KD]:H6WAF_,#Q+I<-D5L7MYW28-]L<@ ,2.
M>N3EN>:?*NXKOL=T9HA&TAD0(O+-NX'UJM9:MIVI,ZV5];W#)]X12!B/RKCM
M6\.S:=IMU]@LE6T(MVEAA&[S-@(8E!UYVD^N.]8VA6]WJFK*EF)HRL#?Z89S
M+Y9,;*5S_#N8AL=!M%-035[B<G>QZH)$;HZGG'![T&1%ZNHYQR:X+2?"-[!9
M76;>6WN5BC,7F7$;!YD.X, BCKC&YCNYYK0MO#$TUWI-SJ%M \B"XGNLD,%G
MD*$8!ZXP<>F*3BNX[OL=:'0D@,I*]1GI5'5=433=,FO543>45!0/C[S =?QK
ME],\.ZA!/; Z=%;26\,J7-VLH8WQ92!GOU(;YNF,"HE\'W-IIT<%E9PQ%]-@
MBG".!OF61&)/J<!N:?+&^X7=CN]Z;BNY=P&2,TNY?[P_.N'3P[J4OC![VYML
MV[S2B2421A7@9"%7&-Y/3.3CT%0V7A76ENK5[MD='=8KL>9UAA(,7XM@Y'^W
M[4N5=PYGV.]9U3&Y@N3@9.*-Z[]FX;O3/-<CJ>FZEJ-W:7U[HD%Z/L[Q-9FX
M&()"W$@)X.1CD<CM4,GAZ_.IL?[/B,[7J7":KYP+11 @^6 ?FX *XZ'.31RK
MN%V=F98QG,B#'7YAQ39_^/:7_</\JXNW\%1F6RDN=-MG8W%W)=EB#O#LQCSZ
M]5..U='I-M<67AJ"VN_]?% 48;MV,9QS],5,TE%V8XMW)C>1Z=H!O959HX+?
MS&"#D@#/'O4MA=RWD!DFL9[,YX2<H21Z_*Q%4K^UEOO"5S:0*&FFM&1%)QDE
M<#GM3O#]N]M8M&]A<6>&^Y/=>>3QU#;FP/:III>S0Y?$:U%%%, HHILB&2)T
M#LA92 RXRON,]Z *>IZO9:1 DUY(P61]B+'&TC,V"<!5!)X!_*J$_B_1[>&*
M=I;AH98Q(LL=K(Z8)QR0I .>,'D5GW/A>\M])?[-J5_<:A'.\]K(7C4HSEL_
MPXP0QSG/MBK0T.X@T?2='1C- D@>\F+8W8)<\?[3U=HDW9?3Q#ICZJNFB=OM
M+9"@Q,%8@9*AL8)QVSFI=4UFRT>-'O'D <G'EPO(>.I(4' ]ZRI#J5]XF1+C
M2[B*Q@W"WN$ECP&*D>81G.>P&.YS3=:LM2@T9K*UDU2_,Q;=-'/$DJ<<#)4#
M;UZ<T65T%W8Z*">*Y@CG@<212*&1EZ$'H:HRZ_IL-E<7C7!^SP2^2SJC'+Y
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/MG^345=HK3V?FR>;R/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g483289g73m29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483289g73m29.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1"&17AI9@  34T *@    @  P$Q  (
M   @   (/H=I  0    !   (7NH<  <   @,    ,@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                 $%D;V)E(%!H;W1O<VAO<"!#4S4N
M,2!-86-I;G1O<V@   'J'  '   (#   "'      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MQV(L@!QR3M49ZY -;2O%N@ZG?6EG9W<KRWEM]JMBUK*B2QC&=KLH4D9!*YW
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MJD=K+Y5QOT:[4P'8'RX,647:P.\@+[UH6_B31Y]:71TGF6[>,R1>9:RI',H
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M)0V!P5^TC YSY0Z9XOW'A/Q;87^LW6C-:$:HL,+G[08Y8XDGN';8VT@,RS@
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MZ 5U^0_QH ]H_P"%D^#_ /H*?^0G_P */^%D^#_^@K_Y!?\ PKQ?_A!O%O\
MT KK\A_C1_P@WBW_ * 5U^0_QH ]H_X63X/_ .@I_P"0G_PH_P"%D^#_ /H*
M?^0G_P *\7_X0;Q;_P! *Z_(?XT?\(-XM_Z 5U^0_P : /:/^%D^#_\ H*?^
M0G_PH_X63X/_ .@I_P"0G_PKQ?\ X0;Q;_T KK\A_C1_P@WBW_H!77Y#_&@#
MVC_A9/@__H*?^0G_ ,*/^%D^#_\ H*?^0G_PKQ?_ (0;Q;_T KK\A_C1_P (
M-XM_Z 5U^0_QH ]H_P"%D^#_ /H*?^0G_P */^%D^#_^@I_Y"?\ PKQ?_A!O
M%O\ T KK\A_C1_P@WBW_ * 5U^0_QH ]H_X63X/_ .@I_P"0G_PH_P"%D^#_
M /H*?^0G_P *\7_X0;Q;_P! *Z_(?XT?\(-XM_Z 5U^0_P : /:/^%D^#_\
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MA_C1_P (-XM_Z 5U^0_QH ]H_P"%D^#_ /H*?^0G_P */^%D^#_^@I_Y"?\
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M .@I_P"0G_PH_P"%D^#_ /H*?^0G_P *\7_X0;Q;_P! *Z_(?XT?\(-XM_Z
M5U^0_P : /:/^%D^#_\ H*?^0G_PH_X63X/_ .@I_P"0G_PKQ?\ X0;Q;_T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<EX_P##-_KESHNIZ/J4-AJNC737%J]Q 986#QM&ZNH(
M/*L<$$8(%=;10!P^K>&_%'B#P7J>BZ_K6G+>3E'LKK3[1X_L[HRNC%6=MV'4
M'@CCBJ=KX#U.72;TZOJUK-JVH:[;:M=3PVQ6,+ T6R)03G 2$#))Y)->B44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
